Prospective open-label pilot study of rimegepant as a treatment for cluster headache

Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo

Nurtec ODT (rimegepant ODT) - Pfizer

Robertson, C.E.1; Stern, J.I.1; Chiang, C.1; Mark, W.A.1; Burke, K.2; Cutrer, F.M.1; Kissoon, N.R.1

Jun 11, 2026